As filed with the Securities and Exchange Commission on March 1, 2021
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Adverum Biotechnologies, Inc.
(Exact name of Registrant as specified in its charter)
| | |
Delaware | | 20-5258327 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification Number) |
800 Saginaw Drive
Redwood City, California 94063
(Address, including zip code, of Registrant’s principal executive offices)
2014 Equity Incentive Award Plan, as amended and restated
2014 Employee Stock Purchase Plan, as amended and restated
2017 Inducement Plan, as amended and restated
(Full title of the plans)
Peter Soparkar
Chief Legal Officer
Adverum Biotechnologies, Inc.
800 Saginaw Drive
Redwood City, California 94063
(650) 656-9323
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
Kenneth Guernsey
CooleyLLP
101 California Street, 5th Floor
San Francisco, CA 94111-5800
(415) 693-2000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | |
Large accelerated filer | | ☒ | | Accelerated filer | | ☐ |
| | | |
Non-accelerated filer | | ☐ | | Smaller reporting company | | ☐ |
| | | |
| | | | Emerging growth company | | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
CALCULATION OF REGISTRATION FEE
| | | | | | | | |
|
Title of Securities to be Registered | | Amount to be Registered(1) | | Proposed Maximum Offering Price Per Share(5) | | Proposed Maximum Aggregate Offering Price | | Amount of Registration Fee |
Common Stock, par value $0.0001 per share | | | | | | | | |
2014 Equity Incentive Award Plan, as amended and restated | | 3,901,953 shares (2) | | $12.64 | | | | |
2014 Employee Stock Purchase Plan, as amended and restated | | 94,301 shares (3) | | $12.64 | | | | |
2017 Inducement Plan, as amended and restated | | 1,500,000 shares (4) | | $12.64 | | | | |
TOTAL | | 5,496,254 shares | | $12.64 | | $69,472,650.56 | | $7,579.47 |
|
|
(1) | Pursuant to Rule 416 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s Common Stock that become issuable under the plans set forth herein by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of the Registrant’s Common Stock. |
(2) | Represents shares of Common Stock that were added to the shares reserved for issuance under the Registrant’s 2014 Equity Incentive Award Plan, as amended and restated, on January 1, 2021, pursuant to an “evergreen” provision contained in such plan. |
(3) | Represents shares of Common Stock that were added to the shares reserved for issuance under the Registrant’s 2014 Employee Stock Purchase Plan, as amended and restated, on January 1, 2021, pursuant to an “evergreen” provision contained in such plan. |
(4) | Represents shares of Common Stock that were added to the shares reserved for issuance under the Registrant’s 2017 Inducement Plan, as amended and restated, on February 19, 2021. |
(5) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(h) and Rule 457(c) promulgated under the Securities Act. The offering price per share and the aggregate offering price are based upon the average of the high and low prices of the Registrant’s Common Stock as reported on The Nasdaq Global Market on February 22, 2021. |